Whole genome sequencing resource identifies 18 new candidate genes for autism spectrum disorder
By Ryan K C Yuen, Daniele Merico, M. Bookman, Jennifer L Howe, B. Thiruvahindrapuram, R. Patel, J. Whitney, N. Deflaux, J. Bingham, Zhuozhi Wang and 73 more. Nature Neuroscience, 2017
752 citations recorded by the source corpus.
We are performing whole-genome sequencing of families with autism spectrum disorder (ASD) to build a resource (MSSNG) for subcategorizing the phenotypes and underlying genetic factors involved. Here we report sequencing of 5,205 samples from families with ASD, accompanied by clinical information, creating a database accessible on a cloud platform and through a controlled-access internet portal. We found an average of 73.8 de novo single nucleotide variants and 12.6 de novo insertions and deletions or copy number variations per ASD subject. We identified 18 new candidate ASD-risk genes and found that participants bearing mutations in susceptibility genes had significantly lower adaptive ability (P = 6 × 10−4). In 294 of 2,620 (11.2%) of ASD cases, a molecular basis could be determined and 7.2% of these carried copy number variations and/or chromosomal abnormalities, emphasizing the importance of detecting all forms of genetic variation as diagnostic and therapeutic targets in ASD.
Subfields: Cognitive Neuroscience, Genetics
View Paper: https://www.semanticscholar.org/paper/0f2aaa0b89fa4dbfee5d92e71b44e7686d13e2c9
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Genetics
Citations in the corpus
- A saturation mutagenesis approach to understanding PTEN lipid phosphatase activity and genotype-phenotypes relationships (2018, background): “PTEN mutations have been identified in macrocephaly cohorts of individuals with formal ASD diagnoses or developmental delay (DD)/intellectual disability (ID)(13,21,22) as well as idiopathic ASD.(14,23,24) It is currently impossible to predict the phenotypic outcome of a given PTEN mutation.”